<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). Abstract Therapeutic options for" exact="coronavirus disease 2019" post="are desperately needed to respond to the ongoing severe"/>
 <result pre="and immunomodulators might have their place in the management of" exact="coronavirus disease 2019." post="Unfortunately, no drugs have been approved yet to treat"/>
 <result pre="discuss the potential of these therapies for the treatment of" exact="coronavirus disease 2019." post="SARS-CoV-2 COVID-19 treatment antiviral drugs immunomodulators Introduction Approximately 15%"/>
 <result pre="SARS-CoV-2 COVID-19 treatment antiviral drugs immunomodulators Introduction Approximately 15% of" exact="coronavirus disease 2019" post="(COVID-19) patients will develop severe lung disease. It is"/>
 <result pre="that showed antiviral activity in animal models for SARS-CoV-1 and/or" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), two other coronaviruses causing severe disease, are"/>
 <result pre="experimental drug that was under development for the treatment of" exact="Ebola" post="virus-infected patients.14 Remdesivir is a nucleotide prodrug that inhibits"/>
 <result pre="and therefore halt viral RNA replication. Despite potent efficacy in" exact="Ebola" post="virus animal models, remdesivir was less efficacious in a"/>
 <result pre="of an FDA-approved compound library identifies four small-molecule inhibitors of" exact="Middle East respiratory syndrome" post="coronavirus replication in cell culture. Antimicrob Agents Chemother2014; 58:"/>
 <result pre="collab: the PALM Writing Group. A randomized, controlled trial of" exact="Ebola" post="virus disease therapeutics. N Engl J Med2019; 381: 2293â€&quot;2303.31774950"/>
 <result pre="Virol2004; 31: 69â€&quot;75.15288617 21ChanJFWChanKHKaoRYT, et al.Broad-spectrum antivirals for the emerging" exact="Middle East respiratory syndrome" post="coronavirus. J Infect2013; 67: 606â€&quot;616.24096239 22ChanJF-WYaoYYeungM-L, et al.Treatment with"/>
 <result pre="399â€&quot;406.14660806 24SpanakisNTsiodrasSHaagmansBL, et al.Virological and serological analysis of a recent" exact="Middle East respiratory syndrome" post="coronavirus infection case on a triple combination antiviral regimen."/>
 <result pre="25KimUJWonEJKeeSJ, et al.Combination therapy with lopinavir/ritonavir, ribavirin and interferon-a for" exact="Middle East respiratory syndrome." post="Antivir Ther2016; 21: 455â€&quot;459.26492219 26LimJJeonSShinHY, et al.Case of the"/>
 <result pre="al.Case of the index patient who caused tertiary transmission of" exact="coronavirus disease 2019" post="in Korea: the application of lopinavir/ritonavir for the treatment"/>
</results>
